Coignard, J.,
Lush, M.,
Beesley, J.,
O’Mara, T.A.,
Dennis, J,
Tyrer, J.P.,
Barnes, D.R.,
McGuffog, L.,
Leslie, G.,
Bolla, M.K.,
Adank, M.A.,
Kiiski, J.I.,
Nevanlinna, H.,
team of authors (2021) Breast cancer (BC) risk for BRCA1 and BRCA
2 mutation carriers varies by genetic and familial
Mingyu, He,
Gege, Yan,
Yang, Wang,
Gong, Rui,
Lei, Hong,
Yu, Shuting,
He, Xiaoqi,
Li, Guanghui,
Du, Weijie,
Ma, Tianshuai,
Gao, Manqi,
Yu, Meixi,
Liu, Shenzhen,
Xu, Zihang,
Idiiatullina, Elina,
Zagidullin, Naufal,
Pavlov, Valentin,
Cai, Benzhi,
Yuan, Ye,
Yang, Lei (2021) production through increased NADPH oxidase enzymes NOX
2 and NOX4, as well as decreased Catalase (CAT
by the modifications of cell cycle-related genes or regulation of
growth-related signals. Additionally, non
Kochetova, OV,
Avzaletdinova, DS,
Shangareeva, ZA,
Akhmadishina, LZ,
Korytina, GF,
Victorov, VV,
Victorova, TV (2021) receptor (HTR
2A rs6313, rs6311), brain-derived neurotrophic
factor (BDNF rs925946, rs11030107
Bayburina, G,
Nurgaleeva, E,
Samigullina, A,
Farshatova, E,
Agletdinov, E,
Tarasova, T,
Mosina, L,
Ryzhakin, S,
Khaydar, D (2021) of corticosteroid
receptors in the kidneys of rats at different times after systemic ischemia-reperfusion. METHODS
ТРАНСФОРМИРУЮЩИЙ ФАКТОР РОСТА β1 И РЕМОДЕЛИРОВАНИЕ МИОКАРДА У ПАЦИЕНТОВ С ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ ИШЕМИЧЕСКОГО ГЕНЕЗАЗАКИРОВА, Н.Э.,
ЗАКИРОВА, А.Н.,
НИЗАМОВА, Д.Ф.,
ZAKIROVA, N.E.,
ZAKIROVA, A.N.,
NIZAMOVA, D.F. (2021) зарегистрированы у пациентов с ХСН IV ФК (77,
2±6,33 нг/мл при ХСН IV ФК против 46,7±3,74 нг/мл и 58,9±4,75 нг